Document Detail


Malignant primary cardiac tumours.
MedLine Citation:
PMID:  22922450     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVES: Management of malignant tumours of the heart remains a poorly investigated clinical area due to the scarcity of presentations. The purpose of this series and review is to present an outline of the management emphasized by our personal experience in a regional cardiothoracic centre.
METHODS: We reviewed all cases presenting with primary cardiac tumours in our institution within the last 10 years, looking at presentation, management and outcomes.
RESULTS: Of these, the records of 3 patients, who attended the Royal Victoria Hospital in Belfast and were treated for a cardiac sarcoma, were fully evaluated. A review of current literature was conducted through a search of Pubmed and Medline databases. A review of the presentation of these patients and the generally accepted management deterioration of patients diagnosed with cardiac sarcoma is discussed.
CONCLUSIONS: With reference to our case series, we want to draw attention to the rapid deteriation of these patients following presentation.
Authors:
Nathan Burnside; Simon W MacGowan
Publication Detail:
Type:  Case Reports; Journal Article; Review     Date:  2012-08-24
Journal Detail:
Title:  Interactive cardiovascular and thoracic surgery     Volume:  15     ISSN:  1569-9285     ISO Abbreviation:  Interact Cardiovasc Thorac Surg     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-11-20     Completed Date:  2013-05-06     Revised Date:  2013-12-05    
Medline Journal Info:
Nlm Unique ID:  101158399     Medline TA:  Interact Cardiovasc Thorac Surg     Country:  England    
Other Details:
Languages:  eng     Pagination:  1004-6     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma / complications,  pathology,  therapy*
Cardiac Surgical Procedures* / adverse effects
Chemotherapy, Adjuvant
Deoxycytidine / administration & dosage,  analogs & derivatives
Doxorubicin / administration & dosage
Fatal Outcome
Female
Heart Neoplasms / complications,  pathology,  therapy*
Humans
Ifosfamide / administration & dosage
Male
Middle Aged
Myxoma / complications,  pathology,  therapy*
Neoplasm Recurrence, Local
Reoperation
Sarcoma / complications,  pathology,  therapy*
Taxoids / administration & dosage
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Taxoids; 0W860991D6/Deoxycytidine; 15H5577CQD/docetaxel; 80168379AG/Doxorubicin; B76N6SBZ8R/gemcitabine; UM20QQM95Y/Ifosfamide
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Do all patients with prosthetic valve endocarditis need surgery?
Next Document:  Pharmacokinetic analysis of multi PEG-theophylline conjugates.